Hra Pharma Rare Diseases
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Avenue De Paris, Chatillon-la-Borde,...Phone Number
+33 140339314Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Hra Pharma Rare Diseases
Esteve Pharma is a dynamic and forward-thinking international specialty pharmaceutical company with a strong presence in Europe, particularly in the Benelux, France, Germany, Italy, Portugal, Spain, and the UK. The company focuses on contract development and manufacturing services (CDMO) for small-molecule active pharmaceutical ingredients, aiming to improve people's lives through innovative therapeutic solutions. Esteve is committed to addressing high unmet medical needs and enhancing global well-being through its diverse portfolio and partnerships. With a dedication to sustainability and ethical practices, Esteve strives to be a leader in the healthcare industry.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hra Pharma Rare Diseases your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Hra Pharma Rare Diseases has recently received funding, and reach out quickly before it becomes old news!
Click to see if Hra Pharma Rare Diseases had a recent Job posting/layoffs
Earning: See what the market has to say on Hra Pharma Rare Diseases recently announced quarterly report
Product Launch: Get notified when Hra Pharma Rare Diseases launches new products
Check out if Hra Pharma Rare Diseases is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Hra Pharma Rare Diseases
Funding: Get notified immidiatlly once Hra Pharma Rare Diseases has new funding data
Hra Pharma Rare Diseases, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Hra Pharma Rare Diseases is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hra Pharma Rare Diseases is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hra Pharma Rare Diseases.
Hra Pharma Rare Diseases Tech Stack
A closer look at the technologies used by Hra Pharma Rare Diseases
Hra Pharma Rare Diseases News & Media
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consideration of up to €275 Million, Consisting of €190 Million in Cash Upfront and up to €85 Million in Potential Earnouts; Based on 2023 Adjusted...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hra Pharma Rare Diseases
Sign Up For FreeTo access detailed company insights
Esteve Pharma is a dynamic and forward-thinking international specialty pharmaceutical company with a strong presence in Europe, particularly in the Benelux, France, Germany, Italy, Portugal, Spain, and the UK. The company focuses on contract development and manufacturing services (CDMO) for small-molecule active pharmaceutical ingredients, aiming... Read More
